CJ Bioscience Inc
KOSDAQ:311690
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
CJ Bioscience Inc
Total Current Liabilities
CJ Bioscience Inc
Total Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
C
|
CJ Bioscience Inc
KOSDAQ:311690
|
Total Current Liabilities
₩14.8B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
46%
|
CAGR 10-Years
N/A
|
|
|
I
|
Infinitt Healthcare Co Ltd
KOSDAQ:071200
|
Total Current Liabilities
₩40.2B
|
CAGR 3-Years
14%
|
CAGR 5-Years
15%
|
CAGR 10-Years
7%
|
|
|
U
|
UBCare Co Ltd
KOSDAQ:032620
|
Total Current Liabilities
₩35.9B
|
CAGR 3-Years
14%
|
CAGR 5-Years
1%
|
CAGR 10-Years
8%
|
|
|
L
|
LifeSemantics Corp
KOSDAQ:347700
|
Total Current Liabilities
₩13.1B
|
CAGR 3-Years
78%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
L
|
Lunit Inc
KOSDAQ:328130
|
Total Current Liabilities
₩7.2B
|
CAGR 3-Years
-56%
|
CAGR 5-Years
-40%
|
CAGR 10-Years
N/A
|
|
|
J
|
JLK Inc
KOSDAQ:322510
|
Total Current Liabilities
₩24.1B
|
CAGR 3-Years
123%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
CJ Bioscience Inc
Glance View
CJ Bioscience, Inc. engages in the research and development of biotechnology and in the provision of solutions for microbiological researches including biomedicine, institutional research and development and genetic sequencing. The company is headquartered in Seoul, Seoul. The company went IPO on 2019-12-26. The firm mainly provides microbial bioinformatics analysis services and microbiome-based healthcare services through bioinformatics database and cloud analytics platform. The firm also develops microbiome therapies and infection diagnosis solutions.
See Also
What is CJ Bioscience Inc's Total Current Liabilities?
Total Current Liabilities
14.8B
KRW
Based on the financial report for Sep 30, 2025, CJ Bioscience Inc's Total Current Liabilities amounts to 14.8B KRW.
What is CJ Bioscience Inc's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
46%
Over the last year, the Total Current Liabilities growth was 4%. The average annual Total Current Liabilities growth rates for CJ Bioscience Inc have been -23% over the past three years , 46% over the past five years .
